loading...

January 2012 Drug Safety Quarterly

This edition includes a vaccination primer for rheumatologists, update on TNF inhibitor-induced psoriasis, drug shortage updates, safety signals and more. READ THE DSQ.

Request for Comments: RA Clinical Trials

The ACR is seeking feedback on the FDA's guidance document for clinical trials in rheumatoid arthritis—last updated in 1999. After meeting with the FDA in September, three priority areas were identified for expedited revision. For complete information on the priority areas and to submit comments by February 15th, visit the request for comments page.

Request for Proposals: RA Clinical Trials

The ACR Research and Education Foundation is currently soliciting applications for investigator-initiated clinical trials that address clinical aspects of rheumatoid arthritis. All applicants must submit a letter of intent via the online submission form no later than March 1, 2012. Applications must be postmarked by May 1, 2012.

State of the Art Clinical Symposia